Tag

Drug Resistant

All articles tagged with #drug resistant

California Faces Surge of Drug-Resistant Candida auris in Hospitals
health-and-medicine7 days ago

California Faces Surge of Drug-Resistant Candida auris in Hospitals

California now accounts for the most Candida auris cases in the U.S.—972 in 2026 as of Aug. 9—out of more than 4,500 nationwide, as this drug-resistant yeast continues to cause severe infections in hospitals and nursing facilities; the organism is frequently resistant to antifungal drugs and outbreaks have risen since 2019, with about 34% mortality in 2017–2022. Prevention centers on strict hand hygiene, isolating infected patients, thorough room disinfection, gloves and gowns for staff, and hand hygiene for visitors.

Georgia Sees Jump in Drug-Resistant Fungus Cases, CDC Reports
health14 days ago

Georgia Sees Jump in Drug-Resistant Fungus Cases, CDC Reports

Georgia is seeing a rise in Candida auris, a drug-resistant fungus, with 193 cases reported in 2026. The organism spreads easily in hospitals and nursing homes, can survive on surfaces and medical equipment, and can cause severe infections that are often resistant to multiple antifungal drugs. The CDC warns of nationwide growth of C. auris, and Georgia requires reporting of cases; health facilities are increasing screening and infection-control measures to prevent transmission.

Candida Auris: Drug-Resistant Fungus Spreads Through Arizona and 27 States
public-health16 days ago

Candida Auris: Drug-Resistant Fungus Spreads Through Arizona and 27 States

A drug-resistant fungal infection caused by Candida auris is spreading across Arizona and other states, with Arizona reporting over 300 cases since 2022 and Pima County cases rising from 31 in 2024 to 59 in 2025. The fungus spreads through contact with affected patients or contaminated surfaces, and its symptoms vary by infection site, making detection challenging. Hand washing is the best prevention, and nationwide data show rising infections in 27 states.

Michigan Confronts Surge of Drug-Resistant Candida Auris in Hospitals
health20 days ago

Michigan Confronts Surge of Drug-Resistant Candida Auris in Hospitals

Michigan hospitals report a surge of Candida auris, a drug-resistant fungus, with over 500 cases this year and more than 3,000 since 2021; the CDC lists it as an urgent threat. It can spread on surfaces in healthcare settings and cause severe infections, including bloodstream infections. Hospitals say increased testing and strict contact precautions are helping, but the risk to people outside hospitals remains low, and patients should follow discharge guidance to reduce exposure.

Drug-resistant Candida auris sparks nationwide health warning
health22 days ago

Drug-resistant Candida auris sparks nationwide health warning

Candida auris, a drug-resistant fungus first detected in the U.S. in 2013, has now been found in 27 states and poses a major threat in healthcare settings, particularly to seriously ill patients with devices such as ventilators, feeding tubes, or catheters. The yeast can persist on surfaces and resist many disinfectants and antifungal medicines, complicating treatment. Infection-control measures in hospitals—private rooms, gowns and gloves, dedicated equipment, and EPA-approved cleaners—are essential to prevent spread, and diagnosis requires lab testing; some strains are resistant to azoles and amphotericin B.

Drug-resistant Candida auris spreads across the U.S.; California leads infections
health22 days ago

Drug-resistant Candida auris spreads across the U.S.; California leads infections

CDC data show Candida auris, a drug-resistant fungus, has been detected in 27 states with about 3,437 clinically confirmed cases through July 25, 2026; the Pacific region bears the heaviest burden, led by California with 873 single-state infections, and the fungus—primarily spread in healthcare settings—is difficult to treat because many strains resist common antifungals; mortality estimates vary, and infection-control measures remain key to limiting spread.

Drug-Resistant Candida auris Expands to 26 States, CDC Reports
health22 days ago

Drug-Resistant Candida auris Expands to 26 States, CDC Reports

The CDC says the drug-resistant fungus Candida auris has spread to 26 states with 3,437 reported cases in 2026, mainly in hospitals and nursing facilities. Infections can range from skin infections to bloodstream infections and may be hard to treat due to antifungal resistance. Transmission occurs via contact and contaminated surfaces; prevention focuses on patient screening, strict hand hygiene, thorough disinfection, patient isolation, and using gloves and gowns during care.

Michigan Faces Alarm Over Drug-Resistant Fungus Candida auris, CDC Warns
health22 days ago

Michigan Faces Alarm Over Drug-Resistant Fungus Candida auris, CDC Warns

CDC warns that Candida auris, a drug-resistant fungus, is spreading in Michigan and across the U.S. Michigan has 3,056 cases since 2021 (503 in 2026 through July 18), with 774 clinical and 2,282 screening cases; Texas leads this year with 706. Nationally, cases rose from 2,882 in 2022 to 6,197 in 2024 and have cooled to about 3,130 in 2026 through July. The fungus can cause infections from skin to bloodstream, spreads in healthcare settings, and is often hard to treat—requiring echinocandin antifungals or combinations due to resistance. Those with severe illnesses or invasive devices are most at risk.

CDC Warns: Drug-Resistant Candida Auris Spreads to 23 States
health22 days ago

CDC Warns: Drug-Resistant Candida Auris Spreads to 23 States

Candida auris, a drug-resistant fungus, has spread to 23 states with more than 3,000 cases in 2026 (3,130 reported by July 18). It mainly threatens people with serious underlying conditions and is difficult to treat due to multi-drug resistance. Transmission occurs in healthcare settings via direct contact, contaminated surfaces, or medical equipment; airborne spread is not believed to occur. Early detection, patient screening, and strict infection-control measures are essential to preventing outbreaks.

Global Spread of Drug-Resistant Candida auris Poses Rising Threat
health8 months ago

Global Spread of Drug-Resistant Candida auris Poses Rising Threat

A dangerous, drug-resistant fungus called Candida auris is spreading globally, posing a serious health threat due to its resistance to treatment and difficulty in diagnosis. It has caused outbreaks in hospitals worldwide, with high mortality rates, and may be linked to climate change. However, advances in antifungal drugs and vaccines offer hope for combating this emerging threat.

"Rapid Spread of Drug-Resistant Fungal Infections Across Multiple US States"
health-public-safety2 years ago

"Rapid Spread of Drug-Resistant Fungal Infections Across Multiple US States"

A drug-resistant and deadly superbug known as Candida auris is spreading in New York State, with the CDC deeming it an "urgent threat" due to its high mortality rate and resistance to antifungal drugs. New York has the third most confirmed cases in the nation, and the rapid rise and geographic spread of cases are concerning. The superbug can be spread in healthcare settings and poses a significant risk to those who are very sick or have invasive medical devices. Symptoms include difficulty swallowing and a burning sensation.

"Washington State Confirms First Outbreak of Deadly Fungus"
health2 years ago

"Washington State Confirms First Outbreak of Deadly Fungus"

Washington state is facing its first known outbreak of the potentially deadly fungus Candida auris, with four patients testing positive in the last month. The source of the infection is currently unknown, and health officials are working to limit its spread in healthcare facilities. C. auris can lead to serious illnesses, particularly in immunocompromised individuals, and some strains are resistant to common antifungal drugs. The CDC recommends proper hand hygiene and disinfection measures to prevent further spread of the fungus.

"Breakthrough Gene Therapy Offers Hope for Children with Drug-Resistant Epilepsy"
health2 years ago

"Breakthrough Gene Therapy Offers Hope for Children with Drug-Resistant Epilepsy"

Researchers at University College London (UCL) have developed a gene-altering medicine that could potentially cure a drug-resistant form of childhood epilepsy called focal cortical dysplasia. By increasing the brain's levels of potassium, the therapy reduces the rate of seizures by limiting the risk of electrical impulses misfiring. Human clinical trials are expected to begin within the next five years.

Breakthrough Pill Reduces Risk of Deadly Drug-Resistant Tuberculosis
health2 years ago

Breakthrough Pill Reduces Risk of Deadly Drug-Resistant Tuberculosis

A commonly available antibiotic pill, levofloxacin, has been found to reduce the risk of contracting drug-resistant tuberculosis (MDR-TB) by 56% in children and 45% in adults, according to new research presented at the Union World Conference on Lung Health. Tuberculosis is the second deadliest infectious disease globally, and MDR-TB poses a significant challenge due to limited treatment options. The study, which followed 453 children exposed to MDR-TB, showed promising results, leading researchers to believe that levofloxacin could offer critical protection to children living with infected parents. The research could potentially protect millions of children from this debilitating illness, and a more child-friendly version of the antibiotic has been developed.

Breakthrough Antibiotic Offers Hope for Drug-Resistant Gonorrhea
health2 years ago

Breakthrough Antibiotic Offers Hope for Drug-Resistant Gonorrhea

A new antibiotic called zoliflodacin has shown promise in treating drug-resistant gonorrhea, according to the results of a late-stage clinical trial. The antibiotic, developed by the Global Antibiotic Research & Development Partnership, cured uncomplicated gonorrhea infections as effectively as the current recommended treatment of ceftriaxone and azithromycin. Gonorrhea has developed resistance to all other antibiotics used to treat it, raising concerns about the emergence of drug-resistant strains. Zoliflodacin, which would be the first new gonorrhea treatment approved in decades, could be on the market by 2025. The World Health Organization has identified gonorrhea as a priority pathogen and warns of the urgent need for new antibiotics.